Please login to the form below
Patient
This page shows the latest Patient news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy
Initial results for the combination therapy – with Merck’s Keytruda – show an overall response rate of 37% in patients with non-small cell lung cancer. ... AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) has shown promising
Latest news
-
Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
Roche and Cend Therapeutics (Cend) will collaborate to evaluate CEND-1 in combination with Roche’s Tecentriq (atezolizumab), and standard-of-care chemotherapy in patients with pancreatic cancer – metastatic pancreatic ductal ... This collaboration
-
Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
EoE is a rare, chronic inflammatory disease of the oesophagus – also known as ‘allergic oesophagitis’ – and its main symptom among patients is swallowing difficulties. ... Upon completion of the ARIA-1 trial, Aqilion plans to apply for drug
-
BMS and 2seventy bio announce positive results for multiple myeloma treatment
Steve Bernstein, chief medical officer, 2seventy bio, said: “The results help to advance our efforts to make Abecma available for earlier lines of treatment for patients. ... Abecma was approved by the US Food and Drug Administration (FDA) in March
-
Sanofi halts recruitment for trials assessing MS treatment
Sanofi highlighted that the decision for a pause was not because of additional safety data and added that all patients who are already involved in the trials will continue to receive ... Sanofi’s head of R&D, John Reed, said: “Patient safety remains
-
Michael J Fox Foundation awards Koneksa second research grant
The grant will used to apply artificial intelligence algorithms retrospectively to a dataset collected from Parkinson’s patients. ... Predictive digital biomarkers will lead to better diagnosis and hopefully life-saving therapies for patients with
More from news
Approximately 212 fully matching, plus 6,257 partially matching documents found.
Latest Intelligence
-
The patient voice – the value of patient-reported outcomes in HTA
For instance, a recent pre-competitive collaboration in Duchenne muscular dystrophy put the patient’s voice first and examined quality of life themes that resonated with patients. ... The questions being asked are about parameters that benefit patients
-
Innovation through collaboration – the importance of partnerships
Through our highly focused R&D, we are striving to improve the lives of patients through innovation. ... The study will also collect data on patients’, physicians’ and therapists’ satisfaction with remote monitoring of patient rehabilitation using
-
Achieving communication excellence by targeting the right channel at the right time
The authentic often out-performs the airbrushed,” he said. “The direction is moving away from the filters and towards the real world of patients and their experiences. ... It is content from a patient perspective with no company logo on it.
-
The pharma dichotomy
Let’s start our planning by asking patients and healthcare professionals what their biggest problems are and challenging ourselves about how we will make their world better, by doing things differently. ... While cultural change takes time, if industry
-
How Resonant’s innovation and creativity resolve healthcare communications challenges
By Stephen Marchant. In the year since Bedrock Group re- branded to become Resonant Group we have enhanced our offer across the spectrum of medical communications, patient insights and PR. ... Origins Insights is a pioneering health insights agency that
More from intelligence
Approximately 104 fully matching, plus 1,058 partially matching documents found.
Latest appointments
-
Hanover appoints Ian Dodge to its senior adviser panel
delivers better outcomes for patients and value for taxpayers.
-
Amanda Pritchard becomes NHS England’s first female chief executive
In her role as COO, Pritchard oversaw NHS operational performance and delivery, as well as the implementation of service transformation and patient care improvements as set out in the NHS Long
-
Ashfield Health announces three new senior hires
Thanks to the tremendous faith and support from our clients, we continue to grow which brings opportunities to hire amazing people and truly #makeitmatter for patients across a wide range of
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer.
-
Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region
Prior to joining Ashfield Engage, Becker served as director of direct to patient services at Marken. ... Serap joins us at an exciting time for Ashfield Engage, as the demand for patient engagement programmes propels across the industry to support
More from appointments
Approximately 2 fully matching, plus 507 partially matching documents found.
Latest from PMHub
-
Live Webinar: Maneuvering the Current Pharma Market to Bring Value to Patients
payer marketing, including the importance of patient-centricity and how to create valuable relationships and true partnerships with payers and HCPs in this hybrid world.
-
EVOKE MIND+MATTER BOLSTERS SENIOR TEAM WITH TRIO OF STRATEGIC HIRES
talented team that focuses on building strong, lasting client partnerships where we work alongside each other for the greater good of making a difference to patients’ lives.”. ... work that really matters for our clients and the patients (and animals!
-
Animation: Living With
The journey from the patient's perspective. Watch our new animation and discover how our Living With syndicated patient reports based on quantitative and qualitative market research with patients, can provide ... you with comprehensive and cost-effective
-
Breaking the silence: It’s time to talk about the menopause
As well as understanding the menopause customer, it is important to understand and support HCPs so that they can offer the right help for their patients. ... If you’re working in this space and would like to get a deeper understanding of patients'
-
6 trends shaping the future of personalized medicine
Personalization is one of the foundations of modern healthcare, advancing how we realize better outcomes for patients and society. ... Related forces like value-based care and patient empowerment are bolstering the movement towards personalization.
More from PMHub
Approximately 492 fully matching, plus 1,034 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Sanofi halts recruitment for trials assessing MS treatment
- Rare Disease Day – looking to the future with hope
- Achieving communication excellence by targeting the right channel at the right time
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
